Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) (the “Company” or “Tarsus”) today announced the pricing of an upsized underwritten public offering of 2,808,988 shares of its common stock at a public ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback